Shutterstock
In personal finance, some moves are better than others. Saving is better than spending. Having a budget is better than impulse buying. Paying off your credit card balance every month is better than getting nailed with finance charges.
But there’s one move that almost never makes sense: Cash advances on credit cards. When you borrow for cash, you get walloped with some of the highest finance charges imaginable.
How obnoxiously high are cash-advance rates? It’s almost like you’re being punished for using a credit card for cash, although banks love their profit margins on these high-rate loans.
According to a recent survey by creditcards.com, here’s how you get bamboozled:
— “High interest, no grace period: The average cash advance Annual Percentage Rate (APR) is 23.68%, much higher than the average purchase APR of 15.79%. Most cash advances have a flat APR irrespective of the individual cardholder’s creditworthiness. There is no grace period for cash advance transactions, meaning borrowers instantly start accruing interest.
investing money: International Lithium Corp. (ILHMF)
Advisors’ Opinion:
- [By SEEKINGALPHA.COM]
International Lithium [TSXV:ILC] (OTCPK:ILHMF) – Price = CAD 0.13
International Lithium (ILC) is a small lithium explorer/project generator with four joint venture lithium projects, and one fully-owned lithium project:
investing money: Aphria Inc. (APHQF)
Advisors’ Opinion:
- [By Javier Hasse]
While biotechs like GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) and Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) only lost 0.45 percent and 0.36 percent respectively, other companies experienced a large tumble. CANOPY GROWTH CORP COM NPV (OTC: TWMJF) lost 4.71 percent, AURORA CANNABIS IN COM NPV (OTC: ACBFF) slipped 2.93 percent, APHRIA INC COM NPV (OTC: APHQF) dropped 1.01 percent, and MassRoots Inc (OTC: MSRT) plummeted an astounding 9.00 percent.
- [By Javier Hasse]
Check out Part 2 of this article, where Phillips shares a look at some other notable transactions announced last week, featuring Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE), Aphria Inc (OTC: APHQF), Invictus MD (OTC: IVITF) and more.
- [By Javier Hasse]
Also quite recently, Benzinga asked Alan Brochstein, founding partner at New Cannabis Ventures and founder at 420 Investor, about plays in the marijuana industry against such an uncertain backdrop. The expert mentioned a few Canadian Licensed Producers, including AURORA CANNABIS IN COM NPV (OTC: ACBFF), APHRIA INC NPV (OTC: APHQF), METTRUM HEALTH COR COM NPV (OTC: MQTRF), ORGANIGRAM HLDGS I COM NPV (OTC: OGRMF), SUPREME PHARMACEUT COM NPV (OTC: SPRWF) and CANOPY GROWTH CORP COM NPV (OTC: TWMJF), as well as “the only” biotech stock in the space, GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH).
- [By Sean Williams]
This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.
GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%
As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!
investing money: JP Energy Partners LP(JPEP)
Advisors’ Opinion:
- [By WWW.GURUFOCUS.COM]
For the details of ArcLight Capital Partners, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=ArcLight+Capital+Partners%2C+LLC
These are the top 5 holdings of ArcLight Capital Partners, LLCEnable Midstream Partners LP (ENBL) – 43,585,926 shares, 67.58% of the total portfolio. American Midstream Partners LP (AMID) – 13,977,709 shares, 19.28% of the total portfolio. Shares added by 230.89%TransMontaigne Partners LP (TLP) – 3,166,704 shares, 13.14% of the total portfolio. JP Energy Partners LP (JPEP) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%Added: Am
investing money: Oil States International Inc.(OIS)
Advisors’ Opinion:
- [By Michael J. Carr]
Einhorn selects investments with a traditional value approach, although he may not be as patient as a typical value investor. Einhorn took Apple (Nasdaq: AAPL) to court in an effort to force the company to return cash to shareholders, and more recently challenged Oil States International (NYSE: OIS) to unlock shareholder value.
- [By Wayne Duggan]
Instead, Genargo prefers oil services stocks with the most exposure to the U.S market. Loop names Halliburton Company (NYSE: HAL) as its top large-cap stock pick and Oil States International, Inc. (NYSE: OIS), Newpark Resources Inc (NYSE: NR) and Superior Energy Services, Inc. (NYSE: SPN) as its top small- and mid-cap stocks.
investing money: Barnes Group, Inc.(B)
Advisors’ Opinion:
- [By Dave and Donald Moenning]
For those investors that like the comfort generally provided by a diversified portfolio, here’s an idea that will allow you to (a) maintain a diversified allocation in your portfolio and (b) stay out of trouble when the big, bad bears come to call on an asset class or two.
